Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 15, 2017

Total Value: $1.753B (100.0% shares, 0.0% debt)

Holdings (38)

UTHR UNITED THERAPEUTICS CORP DEL 15.3%
Value $268M Shares 1,868,815 Est. Cost $88.34 Unrealized +44.5%
ABIOMED INC 12.2%
Value $214M Shares 1,903,584 Est. Cost $30.32 Unrealized
CLOVIS ONCOLOGY INC 9.6%
Value $169M Shares 3,804,088 Est. Cost $53.87 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 9.3%
Value $162M Shares 1,960,219 Est. Cost $77.21 Unrealized +11.4%
AMAG PHARMACEUTICALS INC 6.6%
Value $116M Shares 3,344,620 Est. Cost $29.94 Unrealized
ALEXION PHARMACEUTICALS INC 5.0%
Value $87.33M Shares 713,742 Est. Cost $119.75 Unrealized
ZELTIQ AESTHETICS INC 4.3%
Value $74.89M Shares 1,720,763 Est. Cost $29.98 Unrealized
INSM INSMED INC 4.1%
Value $72.06M Shares 5,446,516 Est. Cost $14.56 Unrealized -6.3%
VNDA VANDA PHARMACEUTICALS INC 3.8%
Value $67.04M Shares 4,203,270 Est. Cost $8.70 Unrealized +84.7%
WRIGHT MED GROUP N V 3.4%
Value $59.85M Shares 2,604,593 Est. Cost $23.37 Unrealized
SAGE THERAPEUTICS INC 2.9%
Value $51.57M Shares 1,009,930 Est. Cost $40.00 Unrealized
PRTA PROTHENA CORP PLC 2.8%
Value $48.89M Shares 993,855 Est. Cost $30.77 Unrealized +79.3%
ACAD ACADIA PHARMACEUTICALS INC 2.5%
Value $44.18M Shares 1,532,030 Est. Cost $29.57 Unrealized -10.5%
STAA STAAR SURGICAL CO 2.1%
Value $36.74M Shares 3,386,245 Est. Cost $7.92 Unrealized +28.4%
EPIZYME INC 2.1%
Value $36.73M Shares 3,035,796 Est. Cost $13.44 Unrealized
CELGENE CORP 1.9%
Value $34.17M Shares 295,240 Est. Cost $97.51 Unrealized
ARIAD PHARMACEUTICALS INC 1.9%
Value $33.36M Shares 2,682,017 Est. Cost $7.21 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.8%
Value $31.86M Shares 6,410,030 Est. Cost $6.21 Unrealized +11.4%
KARYOPHARM THERAPEUTICS INC 1.7%
Value $30.08M Shares 3,200,396 Est. Cost $20.34 Unrealized
MOMENTA PHARMACEUTICALS INC 1.5%
Value $26M Shares 1,727,380 Est. Cost $14.10 Unrealized
GILD GILEAD SCIENCES INC 1.3%
Value $22.8M Shares 318,400 Est. Cost $63.20 Unrealized -15.8%
SHIRE PLC 1.2%
Value $21.14M Shares 124,100 Est. Cost $221.47 Unrealized
RIGEL PHARMACEUTICALS INC 0.6%
Value $9.94M Shares 4,176,623 Est. Cost $3.39 Unrealized
AIMMUNE THERAPEUTICS INC 0.4%
Value $7.765M Shares 379,727 Est. Cost $23.85 Unrealized
EXAS EXACT SCIENCES CORP 0.3%
Value $5.304M Shares 396,976 Est. Cost $12.83 Unrealized +25.8%
SUNESIS PHARMACEUTICALS INC 0.2%
Value $4.208M Shares 1,162,473 Est. Cost $4.37 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.2%
Value $3.721M Shares 38,707 Est. Cost $60.82 Unrealized +52.7%
ALIMERA SCIENCES INC 0.2%
Value $3.255M Shares 3,013,793 Est. Cost $4.88 Unrealized
ACELRX PHARMACEUTICALS INC 0.2%
Value $2.685M Shares 1,032,715 Est. Cost $5.54 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.503M Shares 123,686 Est. Cost $6.71 Unrealized +58.1%
INTREXON CORP 0.1%
Value $1.018M Shares 41,900 Est. Cost $28.82 Unrealized
CEMPRA INC 0.1%
Value $953K Shares 340,320 Est. Cost $22.71 Unrealized
IDERA PHARMACEUTICALS INC 0.1%
Value $925K Shares 616,355 Est. Cost $3.70 Unrealized
SOPHIRIS BIO INC 0.0%
Value $692K Shares 247,000 Est. Cost $2.60 Unrealized
ALCOBRA LTD 0.0%
Value $573K Shares 272,788 Est. Cost $5.98 Unrealized
HISTOGENICS CORP 0.0%
Value $506K Shares 302,922 Est. Cost $11.00 Unrealized
DICERNA PHARMACEUTICALS INC 0.0%
Value $456K Shares 158,279 Est. Cost $9.72 Unrealized
ZOGENIX INC 0.0%
Value $358K Shares 29,500 Est. Cost $13.36 Unrealized